Saá Paula, Castilla Joaquín, Soto Claudio
George and Cynthia Mitchell Center for Alzheimer Disease and Related Neurodegenerative Disorders, Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555, USA.
J Biol Chem. 2006 Nov 17;281(46):35245-52. doi: 10.1074/jbc.M603964200. Epub 2006 Sep 18.
Prions are the unconventional infectious agents responsible for transmissible spongiform encephalopathies, which appear to be composed mainly or exclusively of the misfolded prion protein (PrPSc). Prion replication involves the conversion of the normal prion protein (PrPC) into the misfolded isoform, catalyzed by tiny quantities of PrPSc present in the infectious material. We have recently developed the protein misfolding cyclic amplification (PMCA) technology to sustain the autocatalytic replication of infectious prions in vitro. Here we show that PMCA enables the specific and reproducible amplification of exceptionally minute quantities of PrPSc. Indeed, after seven rounds of PMCA, we were able to generate large amounts of PrPSc starting from a 1x10(-12) dilution of scrapie hamster brain, which contains the equivalent of approximately 26 molecules of protein monomers. According to recent data, this quantity is similar to the minimum number of molecules present in a single particle of infectious PrPSc, indicating that PMCA may enable detection of as little as one oligomeric PrPSc infectious particle. Interestingly, the in vitro generated PrPSc was infectious when injected in wild-type hamsters, producing a disease identical to the one generated by inoculation of the brain infectious material. The unprecedented amplification efficiency of PMCA leads to a several billion-fold increase of sensitivity for PrPSc detection as compared with standard tests used to screen prion-infected cattle and at least 4000 times more sensitivity than the animal bioassay. Therefore, PMCA offers great promise for the development of highly sensitive, specific, and early diagnosis of transmissible spongiform encephalopathy and to further understand the molecular basis of prion propagation.
朊病毒是导致传染性海绵状脑病的非常规感染因子,这类疾病似乎主要或完全由错误折叠的朊病毒蛋白(PrPSc)构成。朊病毒的复制涉及正常朊病毒蛋白(PrPC)在感染性物质中微量存在的PrPSc催化下转化为错误折叠的异构体。我们最近开发了蛋白质错误折叠循环扩增(PMCA)技术,以在体外维持感染性朊病毒的自催化复制。在此我们表明,PMCA能够特异性且可重复地扩增极微量的PrPSc。事实上,经过七轮PMCA后,我们能够从羊瘙痒症仓鼠脑1x10(-12)的稀释液开始产生大量PrPSc,该稀释液中所含的蛋白单体分子数量约相当于26个。根据最近的数据,这个数量类似于单个感染性PrPSc颗粒中存在的最小分子数,这表明PMCA可能能够检测到低至一个寡聚体PrPSc感染性颗粒。有趣的是,体外产生的PrPSc注射到野生型仓鼠体内时具有感染性,引发的疾病与接种脑感染性物质所引发的疾病相同。与用于筛查感染朊病毒的牛的标准检测相比,PMCA前所未有的扩增效率使PrPSc检测的灵敏度提高了数十亿倍,并且比动物生物测定的灵敏度至少高4000倍。因此,PMCA在开发高灵敏度、特异性和早期诊断传染性海绵状脑病以及进一步了解朊病毒传播的分子基础方面具有巨大潜力。